Business Environment

Labcorp Earns Top Score on 2024 Disability Equality Index

Labcorp, a leading global life sciences company, announced it has been named a Best Place to Work for Disability Inclusion after earning the top score of 100 on the 2024 Disability Equality Index. The Disability Equality Index is a joint initiative founded by Disability:IN and The American Association of People with Disabilities (AAPD), to help businesses make a positive impact on the unemployment/underemployment of people with disabilities. The Disability Equality Index is the world’s most comprehensive benchmarking tool for Fortune 1000 scope companies to measure disability inclusion inside their organization based on the categories of culture and leadership, enterprise-wide access, employment practices (benefits; recruitment; employment; education; retention and advancement; accommodations), community engagement, supplier diversity and responsible procurement. "Labcorp is committed to creating a culture of inclusion and belonging where our people can thrive including those with visible and invisible disabilities,” said Brenda Wagner, Chief Inclusion, Diversity and Belonging Officer, Labcorp. “This recognition is a testament to our employees – especially those who overcome challenges – to help us serve our patients. Together, we are embracing possibilities and changing lives.” Labcorp’s disability inclusion culture is represented through its employee resource group, EnABLE (Empowering Abilities Beyond Labels for Everyone), which provides resources and workplace awareness of all disabilities, both visible and invisible. Since its inception in 2020, EnABLE has grown to include 1,750 members and seven chapters worldwide. Additional disability inclusion initiatives include Labcorp’s work with the Center for Disability Inclusion, which supports efforts to advance workplace and marketplace inclusion, as well as Level Access, which provides solutions designed to make the digital world accessible to those with physical disabilities. "On the 10th anniversary of the Disability Equality Index, we’re extremely proud of the 542 national and international companies that are taking a proactive role in leading progress towards disability inclusion, setting a benchmark for others to follow. Their dedication to fostering inclusive workplaces not only attracts top talent but also drives innovation and creates sustainable performance in today's global market. Together, we are creating a future where everyone can contribute and thrive,” said Jill Houghton, President and CEO of Disability:IN. In 2024, 542 corporations, including 71 Fortune 100 and 220 Fortune 500, utilized the Disability Equality Index to benchmark their disability inclusion efforts. Labcorp will be honored for its achievements alongside other top-performing companies at the IN Annual Conference & Expo, taking place from this week in Las Vegas, Nevada.

Medpace Recognized with 2024 CRO Leadership Awards

Medpace, a global, full-service clinical research organization (CRO), reaffirms its industry leadership by once again being recognized with CRO Leadership Awards presented by Life Science Leader and Clinical Leader. Medpace received five awards across all categories, including Capabilities, Compatibility, Expertise, Quality, and Reliability. Medpace has a track record of recognition, having received CRO leadership awards in each the last 7 consecutive years. The company is focused on Making the Complex Seamless® for drug sponsors – with a unique, quality-focused operating model, high-caliber study teams that are consistent from project onset to closeout, and integrated services and technology to deliver operational excellence on a global scale. For the 2024 CRO Leadership Awards, Life Science Leader and Clinical Leader teamed up with Industry Standard Research (ISR) to determine award recipients. 42 contract research organizations were assessed on 20+ performance metrics in ISR’s annual CRO Quality Benchmarking survey to determine the CROs that meet or exceed their customers’ expectations in the categories of Capabilities, Compatibility, Expertise, Quality, and Reliability. Medpace was recognized as having exceeded its customers’ expectations across all five categories. Survey respondents were selected from biopharmaceutical companies of all sizes, vetted for CRO decision-making authority, and were asked to evaluate only companies they have worked on an outsourced project in the past 10 months to ensure the data behind the awards are driven by first-hand experience with the CROs being evaluated.

Pierre-Alain Ruffieux joins Cytiva as Chief Operating Officer

Cytiva is strengthening its leadership team with one of the biotechnology industry’s most highly regarded and experienced leaders, Pierre-Alain Ruffieux, who will join as Chief Operating Officer. Pierre-Alain Ruffieux says: "I am honored to join Cytiva in this role. The company mission resonates deeply with my personal passion for innovation and operational excellence. As a former customer, I've always admired the exceptional quality and reliability of Cytiva’s products and services. Leveraging this firsthand experience and working closely with Cytiva’s talented team, I look forward to further enhancing our customer experience and fostering sustainable global growth.” Chris Riley, Cytiva CEO and Danaher Executive Vice President, says: “We’re excited for what Pierre-Alain will bring to our customers with his depth of experience, expertise, and customer perspective. He has a proven track record from serving as CEO of Lonza, one of our largest customers, as well as Head of Global Pharma Technical Operations at Roche, where he oversaw pharmaceutical commercial manufacturing and supply chain operations. I look forward to working with him to sharpen Cytiva’s ability to deliver with quality and on time to our customers and their patients.”

Cyrus Taraporevala Elected to Pfizer’s Board of Directors

Pfizer Inc. announced the election of Cyrus Taraporevala to its Board of Directors, effective immediately. Mr. Taraporevala, age 57, was also appointed to and will join the Audit Committee and Compensation Committee of Pfizer’s Board. Mr. Taraporevala served as President and Chief Executive Officer at State Street Global Advisors from 2017 until his retirement in 2022. Prior to joining State Street, he held numerous leadership roles in asset management, including at Fidelity, BNY Mellon, Legg Mason, and Citigroup. Earlier in his career, Mr. Taraporevala was a partner at McKinsey & Company, based in New York and Copenhagen. He serves on the boards of directors of Shell plc and Bridgepoint Group plc. Mr. Taraporevala received a Bachelor of Commerce in Financial Accounting from Sydenham College, University of Bombay, and a Master of Business Administration from Cornell University. “We are pleased to welcome Cyrus Taraporevala to Pfizer’s Board of Directors,” stated Albert Bourla, Pfizer Chairman and Chief Executive Officer. “He brings vast experience in investment management, financial markets plus leadership and global operations more broadly that will be an asset to Pfizer and enable our shareholders to continue to benefit from a Board representing a balance of experience, competencies and perspectives.”

Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025

Gilead Sciences, Inc. announced that Chief Medical Officer Merdad Parsey, MD, PhD, will leave the company early next year. While the company works to identify a successor, Dr. Parsey will continue as Chief Medical Officer until the first quarter of 2025 and support this transition over the next several months. “On behalf of everyone at Gilead, I want to thank Merdad for his significant contributions as our Chief Medical Officer over the last five years. These were pivotal years for the company as we worked to strengthen and diversify the portfolio, and Merdad played a fundamental role in our success,” said Daniel O’Day, Chairman and Chief Executive Officer, Gilead. “We have more than doubled our portfolio under Merdad’s leadership, and with 54 ongoing clinical trials across virology, oncology, and inflammation, we are well positioned to build on our success for the future.” Dr. Parsey joined Gilead in November 2019 and is responsible for overseeing the company’s global clinical development and medical affairs organizations. During his tenure, he led the growth of the development organization, specifically with the advancement of market leading treatments in virology and the establishment of Gilead’s oncology pipeline and therapeutics. “It has been a privilege to lead the development team, especially as we have worked to deliver transformative medicines for people with HIV, COVID-19, and cancer,” said Dr. Parsey. “I am profoundly excited about the work we have done to build a strong, diverse clinical pipeline that has tremendous potential to deliver on our commitment to improve health for people around the world.”

Hireology Partners With Activated Insights to Tackle Today's Healthcare Talent Shortage

Hireology, the top-rated applicant tracking system (ATS) built for home care and facilities-based care organizations, announced a new integration partnership with Activated Insights (formerly Home Care Pulse), the leading provider of training, recruitment, retention, experience management and recognition tools to improve and grow long-term and post-acute care organizations. Together, the two solutions empower long-term and post-acute care organizations to quickly attract top-tier Caregivers, RN and CNA talent and ensure long-term retention. This partnership comes at a time when the healthcare talent shortage is more alarming than ever before. Experts predict that about 200,000 new nurses will be needed by 2031. On top of that, 18% of new nurses leave their jobs within the first year — leaving organizations with hiring and training costs that range from $28,400 to $51,700 per nurse. "Given the disparity between talent supply and demand along with high turnover rates, remaining fully staffed becomes a nearly impossible task without effective technology and processes," said Adam Robinson, CEO of Hireology. "That's why we're so thrilled to partner with Activated Insights. Together our two platforms provide a true end-to-end solution for remaining competitive in an increasingly challenging healthcare hiring market." Ultimately, the goal of this integration partnership is three-fold. The two technology providers aim to help home care and facilities-based care organizations: Maximize quality hires and minimize turnover: With Hireology's best-in-class ATS and partnerships with top job sites like Indeed, healthcare organizations can attract top-quality nursing candidates. Streamline hiring processes: The integrated capabilities streamline the entire employee lifecycle, from attracting and interviewing candidates to seamlessly onboarding new hires. Recruit & Retain top talent: Activated Insights enables the hiring and retention processes for long-term and post-acute care organizations. With Recruit, you can automate outreach and engagement to connect, qualify, and interview top caregivers faster than ever. Retain focuses on reducing employee turnover, especially during the critical first 100 days when the risk is highest.

Energage Announces the 2024 Top Workplaces Industry Awards

Energage, the leading HR technology and research company behind the Top Workplaces employer recognition program, today announced the 2024 Top Workplaces Industry Awards. The accolades celebrate organizations across ten industries that prioritize employees and drive people-first cultures. Energage’s confidential, research-backed employee engagement survey determines the Top Workplaces awards. Participating companies are measured against the industry’s most comprehensive benchmarks, built upon 18 years of culture research spanning millions of employees and thousands of organizations nationwide. “Receiving a 2024 Top Workplaces industry award is a badge of excellence, highlighting a company’s commitment to fostering people-first cultures,” said Eric Rubino, Energage CEO. “These outstanding workplaces set the standard in their respective industries, and because the awards are grounded in employee feedback, they serve as a testament to their dedication in prioritizing employees.”

Medit Appoints Han Ryu as CEO

Medit, a global leader in dental 3D scanners and digital dentistry solutions, has appointed Han Ryu as its new CEO. Ryu brings with him over three decades of senior management experience in global medical device and healthcare companies, including prominent roles at Siemens Healthineers, Qorvo Biotechnologies, Accelerate Diagnostics, and Bain & Company. Since 2023, he has successfully led Medit North America, driving significant growth in the region through strategic oversight of sales and marketing initiatives. "I am truly honored to lead Medit as CEO. Medit's open innovation model and commitment to improving patient care align perfectly with my vision. We are poised to accelerate the digital dental revolution with a strong emphasis on customer-centric solutions," Ryu commented on his appointment. The recent introduction of the i900 in the United States has marked a notable milestone in the market, showcasing its state-of-the-art technologies. Its user-friendly features, powered by the latest optical engine, have drawn significant attention for enabling seamless and precise scanning across diverse patient cases. This underscores Medit's commitment to delivering cutting-edge solutions that enhance diagnostic accuracy and improve the patient experience. Under Ryu's leadership, Medit will focus on expanding its range of customer-focused digital dentistry innovations, strengthening relationships with strategic channel partners, ensuring that dental professionals receive unparalleled support and service, ultimately delivering the best customer experience in the industry.

Zynex Recognized as a Best Company to Work For

Zynex, Inc.an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it has been recognized for multiple awards by Top Workplaces and the U.S. News & World Report 2024-2025 ratings. Top Workplaces, the nation's most credible employer recognition program, has included Zynex in its 2024 Top Workplaces – Manufacturing list. This adds to Zynex's previous receipt of the 2024 Top Workplaces USA award, featured in USA TODAY, and 2024 Top Workplaces Regional Awards – Denver. With a history spanning 17 years, the Top Workplaces program has surveyed over 27 million employees, spotlighting culture excellence across 60 regional markets. The Top Workplaces USA designation honors the nation's employers of choice. In addition, US News & World Report recently granted Zynex three awards under its"Best Companies to Work For" in 2024-2025 ratings, including "Best in Pharmaceuticals and Health Products", "Best Companies" and "Best in the West". The six metrics that determine the U.S. News' Best Companies to Work For are quality of pay and benefits, work/life balance and flexibility, job and company stability, physical and psychological comfort, belongingness and esteem, and career opportunities and professional development. To calculate the list, U.S. News & World Report only considered companies that were a part of the Russell 3000 index as of June 2023 and had more than 75 Glassdoor reviews written between 2020 and 2023. "We are privileged to be recognized by both Top Workplaces and U.S. News & World Report, recognizing the emphasis we place on our team by developing leaders and sustaining employee well-being," said Thomas Sandgaard, Founder, Chairman, and CEO of Zynex. "We continue to place a high priority on supporting our employees to advance in their careers and maintain work/life balances. By improving on our team's health, benefits and comfort, we can in turn empower them to accelerate progress on business goals including order growth, FDA approvals of next-generation devices, and new therapy products."

Zelis Earns 2024 Great Place to Work Certification in India

Zelis, a leading provider of healthcare technology solutions, achieves Great Place to Work certification in India for the first time. The honor was determined based on local associates’ survey responses related to their experience at Zelis, the workplace culture, and their perception of Company leadership. “It is an exciting time to be at Zelis and to be part of our growing team in India,” says Venu Kandimalla, SVP and General Manager of Zelis India. “Over the past year, we’ve successfully expanded our team and local operations. To be recognized as a regional workplace leader is a testament to the commitment of our associates and the special environment they have created in India.” For Zelis India, the Great Place to Work certification comes just one year after the founding of the local office in Hyderabad, India. Zelis stood out for its ability to deliver exceptional development, learning, wellness, recognition, and corporate giving programs. The Company’s continued commitment to diversity, equity, inclusion, and belonging also separates it from others in the healthcare market. The recognition comes after Zelis celebrated its Great Place to Work certification in the United States for a second consecutive year.